位置:首页 > 蛋白库 > TP4A1_RAT
TP4A1_RAT
ID   TP4A1_RAT               Reviewed;         173 AA.
AC   Q78EG7; Q4QRA5; Q8VH48;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   03-AUG-2022, entry version 135.
DE   RecName: Full=Protein tyrosine phosphatase type IVA 1;
DE            EC=3.1.3.48 {ECO:0000269|PubMed:8196618};
DE   AltName: Full=Protein-tyrosine phosphatase 4a1;
DE   AltName: Full=Protein-tyrosine phosphatase of regenerating liver 1;
DE            Short=PRL-1;
DE   Flags: Precursor;
GN   Name=Ptp4a1; Synonyms=Prl1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CATALYTIC ACTIVITY, ACTIVITY REGULATION,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, INDUCTION, AND MUTAGENESIS OF
RP   CYS-104.
RC   TISSUE=Regenerating liver;
RX   PubMed=8196618; DOI=10.1128/mcb.14.6.3752-3762.1994;
RA   Diamond R.H., Cressman D.E., Laz T.M., Abrams C.S., Taub R.;
RT   "PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell
RT   growth.";
RL   Mol. Cell. Biol. 14:3752-3762(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Basophil;
RA   Heneberg P., Draber P.;
RL   Submitted (NOV-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=8840018; DOI=10.1016/0169-328x(96)00035-6;
RA   Takano S., Fukuyama H., Fukumoto M., Kimura J., Xue J.H., Ohashi H.,
RA   Fujita J.;
RT   "PRL-1, a protein tyrosine phosphatase, is expressed in neurons and
RT   oligodendrocytes in the brain and induced in the cerebral cortex following
RT   transient forebrain ischemia.";
RL   Brain Res. Mol. Brain Res. 40:105-115(1996).
RN   [5]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=10960362; DOI=10.1152/ajpgi.2000.279.3.g613;
RA   Kong W., Swain G.P., Li S., Diamond R.H.;
RT   "PRL-1 PTPase expression is developmentally regulated with tissue-specific
RT   patterns in epithelial tissues.";
RL   Am. J. Physiol. 279:G613-G621(2000).
RN   [6]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=10679780;
RX   DOI=10.1002/(sici)1097-4547(20000201)59:3<430::aid-jnr18>3.0.co;2-7;
RA   Scarlato M., Beesley J., Pleasure D.;
RT   "Analysis of oligodendroglial differentiation using cDNA arrays.";
RL   J. Neurosci. Res. 59:430-435(2000).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 1-160.
RX   PubMed=16142898; DOI=10.1021/bi0509191;
RA   Sun J.-P., Wang W.-Q., Yang H., Liu S., Liang F., Fedorov A.A., Almo S.C.,
RA   Zhang Z.-Y.;
RT   "Structure and biochemical properties of PRL-1, a phosphatase implicated in
RT   cell growth, differentiation, and tumor invasion.";
RL   Biochemistry 44:12009-12021(2005).
CC   -!- FUNCTION: Protein tyrosine phosphatase which stimulates progression
CC       from G1 into S phase during mitosis. May play a role in the development
CC       and maintenance of differentiating epithelial tissues (By similarity).
CC       {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620; EC=3.1.3.48;
CC         Evidence={ECO:0000269|PubMed:8196618};
CC   -!- ACTIVITY REGULATION: Inhibited by sodium orthovanadate and pentamidine.
CC       {ECO:0000269|PubMed:8196618}.
CC   -!- SUBUNIT: Homotrimer. Interacts with ATF5 and tubulin (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q93096}.
CC       Early endosome {ECO:0000250|UniProtKB:Q93096}. Endoplasmic reticulum
CC       {ECO:0000250|UniProtKB:Q93096}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q93096}. Cytoplasm, cytoskeleton, spindle
CC       {ECO:0000250|UniProtKB:Q93096}. Nucleus {ECO:0000269|PubMed:8196618}.
CC       Note=And mitotic spindle. {ECO:0000250|UniProtKB:Q93096}.
CC   -!- TISSUE SPECIFICITY: Brain (neurons and oligodendrocytes), skeletal
CC       muscle, regenerating liver, tumor cell lines. Expressed in enterocytes
CC       of the small intestine villi and colonic surface, zymogen cells of the
CC       stomach, proximal tubule cells of the kidney, bronchiolar epithelium,
CC       but not in esophagus and heart (at protein level).
CC       {ECO:0000269|PubMed:10960362, ECO:0000269|PubMed:8196618,
CC       ECO:0000269|PubMed:8840018}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in fetal brain. Up-regulated during
CC       oligodendroglial differentiation. Expressed in the developing
CC       intestine, esophagus, liver, kidney and lung (at protein level).
CC       {ECO:0000269|PubMed:10679780, ECO:0000269|PubMed:10960362,
CC       ECO:0000269|PubMed:8840018}.
CC   -!- INDUCTION: By hepatectomy, mitogens, and ischemia-reperfusion.
CC       {ECO:0000269|PubMed:8196618}.
CC   -!- PTM: Farnesylated. Farnesylation is required for membrane targeting (By
CC       similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L27843; AAA41935.1; -; mRNA.
DR   EMBL; AY062269; AAL38661.1; -; mRNA.
DR   EMBL; BC081772; AAH81772.1; -; mRNA.
DR   EMBL; BC097307; AAH97307.1; -; mRNA.
DR   RefSeq; NP_113767.1; NM_031579.3.
DR   RefSeq; XP_002727244.1; XM_002727198.5.
DR   RefSeq; XP_006244733.1; XM_006244671.3.
DR   RefSeq; XP_008765001.1; XM_008766779.2.
DR   PDB; 1X24; X-ray; 3.20 A; A/B=1-160.
DR   PDB; 1ZCK; X-ray; 1.90 A; A/B/C=7-160.
DR   PDB; 1ZCL; X-ray; 2.90 A; A/B=1-160.
DR   PDB; 3RZ2; X-ray; 2.80 A; A/B=1-169.
DR   PDBsum; 1X24; -.
DR   PDBsum; 1ZCK; -.
DR   PDBsum; 1ZCL; -.
DR   PDBsum; 3RZ2; -.
DR   AlphaFoldDB; Q78EG7; -.
DR   BMRB; Q78EG7; -.
DR   SMR; Q78EG7; -.
DR   STRING; 10116.ENSRNOP00000016237; -.
DR   jPOST; Q78EG7; -.
DR   PaxDb; Q78EG7; -.
DR   Ensembl; ENSRNOT00000016237; ENSRNOP00000016237; ENSRNOG00000011771.
DR   GeneID; 29463; -.
DR   KEGG; rno:29463; -.
DR   UCSC; RGD:61970; rat.
DR   CTD; 7803; -.
DR   RGD; 61970; Ptp4a1.
DR   eggNOG; KOG2836; Eukaryota.
DR   GeneTree; ENSGT00940000154406; -.
DR   HOGENOM; CLU_099263_1_0_1; -.
DR   InParanoid; Q78EG7; -.
DR   OMA; NGQKNSC; -.
DR   OrthoDB; 1398550at2759; -.
DR   PhylomeDB; Q78EG7; -.
DR   TreeFam; TF313384; -.
DR   EvolutionaryTrace; Q78EG7; -.
DR   PRO; PR:Q78EG7; -.
DR   Proteomes; UP000002494; Chromosome 9.
DR   Bgee; ENSRNOG00000011771; Expressed in skeletal muscle tissue and 19 other tissues.
DR   Genevisible; Q78EG7; RN.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0009898; C:cytoplasmic side of plasma membrane; ISO:RGD.
DR   GO; GO:0005769; C:early endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:RGD.
DR   GO; GO:0005819; C:spindle; IEA:UniProtKB-SubCell.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IDA:RGD.
DR   GO; GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IEA:InterPro.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0030335; P:positive regulation of cell migration; ISO:RGD.
DR   GO; GO:0006470; P:protein dephosphorylation; IEA:InterPro.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR000340; Dual-sp_phosphatase_cat-dom.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; Tyr_Pase_dom.
DR   InterPro; IPR020422; TYR_PHOSPHATASE_DUAL_dom.
DR   Pfam; PF00782; DSPc; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50054; TYR_PHOSPHATASE_DUAL; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell cycle; Cell membrane; Cytoplasm; Cytoskeleton;
KW   Developmental protein; Disulfide bond; Endoplasmic reticulum; Endosome;
KW   Hydrolase; Lipoprotein; Membrane; Methylation; Nucleus; Prenylation;
KW   Protein phosphatase; Reference proteome.
FT   CHAIN           1..170
FT                   /note="Protein tyrosine phosphatase type IVA 1"
FT                   /id="PRO_0000094784"
FT   PROPEP          171..173
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000396730"
FT   DOMAIN          8..161
FT                   /note="Tyrosine-protein phosphatase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160"
FT   REGION          97..132
FT                   /note="Interaction with ATF5"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        72
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        104
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160"
FT   BINDING         105..110
FT                   /ligand="phosphate"
FT                   /ligand_id="ChEBI:CHEBI:43474"
FT                   /evidence="ECO:0000250"
FT   BINDING         110
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         170
FT                   /note="Cysteine methyl ester"
FT                   /evidence="ECO:0000250"
FT   LIPID           170
FT                   /note="S-farnesyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:Q93096"
FT   DISULFID        49..104
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         104
FT                   /note="C->S: Abolishes enzymatic activity."
FT                   /evidence="ECO:0000269|PubMed:8196618"
FT   CONFLICT        170
FT                   /note="C -> W (in Ref. 2; AAL38661)"
FT                   /evidence="ECO:0000305"
FT   STRAND          10..13
FT                   /evidence="ECO:0007829|PDB:1ZCK"
FT   STRAND          18..21
FT                   /evidence="ECO:0007829|PDB:1ZCK"
FT   TURN            27..29
FT                   /evidence="ECO:0007829|PDB:1ZCK"
FT   HELIX           30..39
FT                   /evidence="ECO:0007829|PDB:1ZCK"
FT   STRAND          42..47
FT                   /evidence="ECO:0007829|PDB:1ZCK"
FT   HELIX           56..60
FT                   /evidence="ECO:0007829|PDB:1ZCK"
FT   STRAND          64..67
FT                   /evidence="ECO:0007829|PDB:1ZCK"
FT   STRAND          72..74
FT                   /evidence="ECO:0007829|PDB:3RZ2"
FT   HELIX           78..94
FT                   /evidence="ECO:0007829|PDB:1ZCK"
FT   STRAND          99..103
FT                   /evidence="ECO:0007829|PDB:1ZCK"
FT   STRAND          105..108
FT                   /evidence="ECO:0007829|PDB:1ZCK"
FT   TURN            109..111
FT                   /evidence="ECO:0007829|PDB:1ZCK"
FT   HELIX           112..121
FT                   /evidence="ECO:0007829|PDB:1ZCK"
FT   HELIX           126..134
FT                   /evidence="ECO:0007829|PDB:1ZCK"
FT   STRAND          137..139
FT                   /evidence="ECO:0007829|PDB:3RZ2"
FT   HELIX           143..151
FT                   /evidence="ECO:0007829|PDB:1ZCK"
SQ   SEQUENCE   173 AA;  19815 MW;  702008013D3F3835 CRC64;
     MARMNRPAPV EVTYKNMRFL ITHNPTNATL NKFIEELKKY GVTTIVRVCE ATYDTTLVEK
     EGIHVLDWPF DDGAPPSNQI VDDWLSLVKI KFREEPGCCI AVHCVAGLGR APVLVALALI
     EGGMKYEDAV QFIRQKRRGA FNSKQLLYLE KYRPKMRLRF KDSNGHRNNC CIQ
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024